Zobrazeno 1 - 3
of 3
pro vyhledávání: '"César Depoortere"'
Autor:
Véronique Dziwniel, Alain Duhamel, Nicolas Bertrand, Alain Dupuy, Nicole Basset-Seguin, Laurent Mortier, Philippe Saiag, César Depoortere, S. Dalac-Rat, Pierre Guerreschi
Publikováno v:
EClinicalMedicine
EClinicalMedicine, 2021, 35, pp.100844. ⟨10.1016/j.eclinm.2021.100844⟩
EClinicalMedicine, Vol 35, Iss, Pp 100844-(2021)
EClinicalMedicine, 2021, 35, pp.100844. ⟨10.1016/j.eclinm.2021.100844⟩
EClinicalMedicine, Vol 35, Iss, Pp 100844-(2021)
Background Surgery is the primary treatment for basal cell carcinoma (BCC). In locally advanced basal cell carcinoma (laBCC), surgery may cause functional or aesthetic damage. In laBCC, neoadjuvant administration of vismodegib, an inhibitor of the He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f97103c0504f4679a7ed052b38b143
http://europepmc.org/articles/PMC8093898
http://europepmc.org/articles/PMC8093898
Autor:
Pierre Faglin, Marion Gradwohl, César Depoortere, Nicolas Germain, Anne-Sophie Drucbert, Stéphanie Brun, Claire Nahon, Salim Dekiouk, Alexandre Rech, Nathalie Azaroual, Patrice Maboudou, Julien Payen, Pierre-Marie Danzé, Pierre Guerreschi, Philippe Marchetti
Publikováno v:
Scientific Reports
Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.11779. ⟨10.1038/s41598-020-68776-8⟩
Scientific Reports, 2020, 10 (1), pp.11779. ⟨10.1038/s41598-020-68776-8⟩
Scientific Reports, Vol 10, Iss 1, Pp 1-18 (2020)
Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.11779. ⟨10.1038/s41598-020-68776-8⟩
Scientific Reports, 2020, 10 (1), pp.11779. ⟨10.1038/s41598-020-68776-8⟩
Scientific Reports, Vol 10, Iss 1, Pp 1-18 (2020)
International audience; Tissue engineering chambers (TECs) bring great hope in regenerative medicine as they allow the growth of adipose tissue for soft tissue reconstruction. To date, a wide range of TEC prototypes are available with different conce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1f0eb9497261a1a0db954a5cb996f333
https://www.hal.inserm.fr/inserm-02939267
https://www.hal.inserm.fr/inserm-02939267
Autor:
Nicolas Bertrand, MD, Pierre Guerreschi, MD, PhD, Nicole Basset-Seguin, MD, PhD, Philippe Saiag, MD, PhD, Alain Dupuy, MD, PhD, Sophie Dalac-Rat, MD, Véronique Dziwniel, PhD, César Depoortère, MD, Alain Duhamel, MD, PhD, Laurent Mortier, MD, PhD
Publikováno v:
EClinicalMedicine, Vol 35, Iss , Pp 100844- (2021)
Background: Surgery is the primary treatment for basal cell carcinoma (BCC). In locally advanced basal cell carcinoma (laBCC), surgery may cause functional or aesthetic damage. In laBCC, neoadjuvant administration of vismodegib, an inhibitor of the H
Externí odkaz:
https://doaj.org/article/f1b8766645a74b0ea24097fcc01e4d81